Statistics for Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
Total visits
| views | |
|---|---|
| Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy | 2 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:da50f915-f216-41c2-b00d-38620122fca7 | 32 |
| java.util.UUID:24f8720b-6926-4e78-912c-5204e3554729 | 26 |
| java.util.UUID:49d84465-e887-4a6f-a588-cdcdd5419de5 | 7 |
| Rossing2021Finerenone-CCBYNCND.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |